PATENT CLAIM ANALYSIS

Application Number: 16027951
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["544", "287000"]

Abstract:
The present application discloses compounds which are activators of autophagic flux and pharmaceutical compositions comprising said activators. It further discloses use of said compounds and pharmaceutical compositions in the treatment of neurodegenerative diseases, particularly proteinopathies and tauopathies such as Alzheimer's disease. It further discloses methods of enhancing autophagic flux.

Claim (Index 3):
The compound of  claim 1 , wherein the compound is: or a salt, enantiomer, racemate, mixture thereof, or combination thereof.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15480220', '16027930', '15534855', '15358938', '15031410']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7335548337240515
- 35 USC 102 Novelty (BERT): 0.5284557402469966
- Combined Prediction Score: 0.713044924376346
- Mean Citation Score: 229.261332
- Max Citation Score: 342.53564
- Similarity Product: 302.7220654647064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test